New glucose monitor aims for better accuracy and safety in diabetes care
NCT ID NCT07518004
First seen Apr 09, 2026 · Last updated Jun 22, 2026 · Updated 12 times
Summary
This study is testing a new continuous glucose monitoring system called ROME GS in 60 adults with type 1 or type 2 diabetes. The goal is to see if it measures blood sugar accurately and is safe to use. Participants will wear the sensor and have their glucose levels checked against a standard lab test.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Flourish Research - Diablo Clinical Research
NOT_YET_RECRUITINGWalnut Creek, California, 94598, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Flourish Research - San Antonio
RECRUITINGSan Antonio, Texas, 78229, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Headlands Research - AMCR Institute
RECRUITINGEscondido, California, 92025, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Rainier Clinical Research Center
RECRUITINGRenton, Washington, 98057, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Continuous glucose monitoring system (device)
What this could lead to
If successful, this could lead to a more accurate and safer continuous glucose monitor for people with diabetes, helping them better manage their blood sugar levels.
What could go wrong
This is an early-stage study with only 60 participants, so results may not apply to everyone. The device may not be more accurate or safer than existing monitors, and there are risks like infection or discomfort from sensor insertion.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.